Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Check the time stamp on this data. Updated AI-Generated Signals for Crispr Therapeutics Ag (CRSP) available here: CRSP. Type ...

In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Caribou Biosciences (CRBU – Research ...

Senior Center will offer a home safety and fall screening at 1 p.m. on Tuesday, Jan. 21, at the senior center, 216 Third St. NW. An occupational therapist and physical therapist from Sanford Health ...

Excellus BlueCross BlueShield recently announced the recipients of Health Equity Innovation Awards, designed to support community programs and services that focus on combating racial and ethnic health ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...